New hope for PTSD: drug study targets military and civilian patients
Symptom relief
Not yet recruiting
This study tests a drug called vilazodone to see if it can safely reduce PTSD symptoms in 200 adults, including active-duty service members, veterans, and civilians. Participants will receive either the drug or a placebo, and researchers will measure changes in PTSD severity and …
Phase: PHASE2 • Sponsor: Global Coalition for Adaptive Research • Aim: Symptom relief
Last updated May 22, 2026 14:03 UTC